{
    "url_original": "https://www.wsj.com/articles/covid-19-vaccine-pill-merck-11638225869?mod=business_lead_pos3",
    "url": "covid-19-vaccine-pill-merck-11638225869",
    "title": "Merckâ€™s Covid-19 Pill to Be Reviewed by FDA Advisers",
    "sub_head": "Endorsement of molnupiravir, from Merck and partner Ridgeback, could open the door for FDA authorization before the end of the year",
    "category_1": "Business",
    "category_2": "Health Care",
    "time": "2021-11-30 05:30:00",
    "body": "An outside panel of scientific advisers to the Food and Drug Administration is scheduled to meet Tuesday to discuss the experimental Covid-19 oral antiviral from  Merck  & Co. and partner Ridgeback Biotherapeutics LP.<br />At the end of the meeting, the panel, known as the Antimicrobial Drugs Advisory Committee, is expected to vote on whether to recommend that the agency clear the pill for emergency use, which may be limited to only high-risk people."
}